Zusammenfassung
Beim M. Menière kann es schwerfallen, den Überblick im „Labyrinth“ des schwindelerregenden und höreinschränkenden Geschehens zu behalten, auch wenn sicherlich jeder Experte – auf seinem Gebiet und mit seinen Kenntnissen – sein Möglichstes gibt. So macht es einen Unterschied, wer bei wem in welchem Zustand und Stadium des Geschehens (akut oder chronisch) auf die Krankheit oder den Erkrankten schaut. Ebenfalls wird die Sichtweise eine spezielle sein, ob man eher konservativ oder chirurgisch orientiert ist, auf die Ohren oder das Nervensystem oder „die Psyche“ spezialisiert ist, selbst betroffenen ist oder war oder dem Krankheitsbild eher forschend gegenübersteht.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Adrion C, Fischer CS, Wagner J, Gürkov R, Mansmann U, Strupp M (2016) Efficacy and safety of betahistine treatment in patients with Menière’s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 352:h6816. https://doi.org/10.1136/bmj.h6816
Ammon HPT (1991) Arzneimittelneben- und -wechselwirkungen. Wissenschaftliche Verlagsgesellschaft, Stuttgart
Baier G, Ott I (2008) Die chirurgische Therapie des M. Menière Entwicklung und heutiger Stand. HNO 56:553–566
Balaban CD, Jacob RG, Furman JM (2011) Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother 11(3):379–394. https://doi.org/10.1586/ern.11.19
Basta D, Ernst A (2008) Moderne Rehabilitation von Gleichgewichtsstörungen mit Hilfe von Neurofeedback-Trainingsverfahren. HNO 56:990–995
Basura GJ, Adams ME, Monfared A, Schwartz SR, Antonelli PJ, Burkard R, Bush ML, Bykowski J, Colandrea M, Derebery J, Kelly EA, Kerber KA, Koopman CF, Kuch AA, Marcolini E, McKinnon BJ, Ruckenstein MJ, Valenzuela CV, Vosooney A, Walsh SA, Nnacheta LC, Dhepyasuwan N, Buchanan EM (2020) Clinical practice guideline: Ménière’s disease. Executive summary. Otolaryngology–Head Neck Surg 162(4):415–434
Bertlich M, Ihler F, Spiegel JL, Canis M, Weiss BG (2020) Intratympanal administration of lidocaine in the management of Ménière’s disease. Acta Otolaryngol 16:1–7. https://doi.org/10.1080/00016489.2020.1844289
Boenninghaus HG, Lenarz T (2007) Hals Nasen Ohren Heilkunde. 13. Auf. Springer, Heidelberg
Brandt T, Dieterich M, Strupp M (2021) Vertigo. Leitsymptom Schwindel. 3. Aufl. Steinkopff, Darmstadt
Bronstein A, Lempert T, Pavlou M (2017) Therapie von Schwindel und Gleichgewichtsstörungen. In: Bronstein A, Lempert T (Hrsg) Schwindel. Schattauer, Stuttgart, S 225–234
Buki B, Platz M, Haslwanter T, Junger H, Avan P (2011) Results of electrocochleography in Menière‘s disease after successful vertigo control by single intratympanic gentamicin injection. Audiol Neurootol 16(1):49–54
Burgess A, Kundu S (2010) Diuretics for Menière‘s disease or syndrome. Cochrane Database Syst Rev (4)
Cawthorne TE, Friedmann G (1969) Head movement exercises in the therapy of disorders of the equilibrium. Schweiz Med Wochenschr 99:156–158
Cobb S (1976) Social support as a moderator of life stress. Psychosom Med 38:300–314
Committee on Hearing and Equilibrium (1995) Guidelines for the diagnosis and evaluation of therapy in Menière‘s disease. Otolaryngol Head Neck Surg 113:181–185
Cooksey FS (1946) Rehabilitation in vestibular injuries. Proc R Soc Med 39:273–278
Crane BT, Minor LB, Della Santina CC, Carey JP (2009) Middle ear exploration in patients with Ménière‘s disease who have failed outpatient intratympanic gentamicin therapy. Otol Neurotol 30:619–624
Dandy W (1933) Treatment of Menière‘s disease by section of only the vestibular portion of the acoustic nerve. Bull Johns Hopkins Hosp 53:53
Dazert S, Thomas JP, Loth A, Zahnert T, Stöver T (2020) Cochlear implantation – diagnosis, indications, and auditory rehabilitation results. Dtsch Arztebl Int 117:690–700
Devantier L, Guldfred FL, Djurhuus BD, Handel MN, Schmidt JH, Hougaard DD, Edemann-Callesen H (2019a) Positive pressure device treatment for Meniere’s disease: an overview of the current evidence and a meta-analysis. Eur Arch Otorhinolaryngol 276(5):1263–1273
Devantier L, Schmidt JH, Djurhuus BD, Hougaard DD, Händel MN, Liviu-Adelin Guldfred F, Edemann-Callesen H (2019b) Current state of evidence for endolymphatic sac surgery in Menière’s disease: a systematic review. Acta Otolaryngol 139(11):953–958. https://doi.org/10.1080/00016489.2019.1657240
Devantier L, Hougaard D, Händel MN, Liviu-Adelin Guldfred F, Schmidt JH, Djurhuus B, Callesen HE (2020) Using betahistine in the treatment of patients with Menière’s disease: a meta-analysis with the current randomized-controlled evidence. Acta Otolaryngol 140(10):845–853. https://doi.org/10.1080/00016489.2020.1777326. Epub 2020 Jun 25
Ernst A (2011) Perspektiven der Gleichgewichtsdiagnostik und -therapie. Laryngo-Rhino-Otol 90(Supplement 1):S35–S43
Espinosa-Sanchez JM, Lopez-Escamez JA (2016) Menière’s disease. Handb Clin Neurol 137:257–277
Fisher LM, Derebery MJ, Friedman RA (2012) Oral steroid treatment for hearing improvement in Ménière’s disease and endolymphatic hydrops. Otol Neurotol 33(9):1685–1691. https://doi.org/10.1097/MAO.0b013e31826dba83
Forge A, Li L, Nevill G (1998) Hair cell recovery in the vestibular sensory epithelia of mature guinea pigs. J Comp Neurol 397:69–88
Fowler EP (1948) Streptomycine treatment of vertigo. Trans Am Acad Ophthalmol Otol 53:293–301
Franz P, Hamzavi JS, Schneider B, Ehrenberger K (2003) Do middle ear muscles trigger attacks of Menière’s disease? Acta Otolaryngol 123:133–137
Friese K (1995) Erweiterung unserer Therapiemöglichkeiten durch Homöopathie bei Tinnitus und Morbus Menière. Tinnitus Forum 2:11–14
Gabra N, Asmar MH, Berbiche D, Saliba I (2016) Endolymphatic duct blockage: quality of life assessment of a novel surgical technique for Menière disease. Eur Arch. https://doi.org/10.1007/s00405-015-3890-4
Gacek RR (2015) Recovery of hearing in Meniere’s disease after antiviral treatment. Am J Otolaryngol 36(3):315–323
Gleich O, Strutz J, Schmid K (2008) Endolymph-Homöostase und M. Menière Grundlagen, pathologische Veränderungen, Aminoglykoside. HNO 56:1243–1252
Gottshall KR, Hoffer ME, Moore RJ (2005) The role of vestibular rehabilitation in the treatment of Menière‘s disease. Otolaryngol Head Neck Surg 133(3):p326–p328
Grace E (2010) Rehabilitation of the patient with Ménière’s disease. In: Ruckenstein MJ (Hrsg) Ménière’s disease. Evidence an outcomes. Plural publishing, San Diego/Oxford/Brisbane, S 123–134
Gstöttner W, Adunka O (2004) Labyrinthanästhesie bei M. Menière. HNO 52:265
Harcourt JP, Lambert A, Wong PY, Patel M, Agarwal K, Golding JF, Bronstein AM (2019) Long-term follow-up of intratympanic methylprednisolone versus gentamicin in patients with unilateral Menière’s disease. Otol Neurotol 40(4):491–496. https://doi.org/10.1097/MAO.0000000000002108
Helling K (2008) Otolithenfunktionsstörungen und Therapieoptionen. HNO 56:996–1002
Helling K (2015) HNO update. Vestibuläre Störungen. In: Iro H, Werner JA (Hrsg) HNO Update 2015 – Handbuch HNO 2015/2016. med update, Wiesbaden
Helms J (1985) Die chirurgische Therapie des Morbus Menière. In: Verhandlungsbericht der Deutschen Gesellschaft für Hals-Nasen-Ohrenheilkunde. Arch Otorhinolaryngol Suppl 1:67–118
Herdman SJ (2000) Vestibular rehabilitation, 3. Aufl. Contemporary perspectives in rehabilitation. F.A. Davis Company, Philadelphia
Hillier SL, McDonnell M (2011) Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev (2):CD005397
Hillman TA, Chen DA, Arriaga MA (2004) Vestibular nerve section versus intratympanic gentamicin for Menière‘s disease. Laryngoscope 114(2):216–222
Hoffmann SO (2008) Psychodynamische Therapie von Angststörungen. Einführung und Manual für die kurz- und mittelfristige Therapie. Schattauer, Stuttgart
Holmberg J, Karlberg M, Harlacher U, Magnusson M (2007) One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol 254:1189e92
Huang TS (Hrsg) (1991) Menière‘s disease: recent advances in basic and clinical aspects. Acta Otolaryngol Suppl 485:7–154
Huon LK, Fang TY, Wang PC (2012) Outcomes of intratympanic gentamicin injection to treat Menière’s disease. Otol Neurotol 33:706–714
Hussain K, Murdin L, Schilder AG. (2018) Restriction of salt, caffeine and alcohol intake for the treatment of Meniere’s disease or syndrome. Cochrane Database Syst Rev 12:Cd012173
Jahnke K (1994) Stadiengerechte Therapie der Menièreschen Krankheit. Dtsch Arztebl 91:428–434
James AI, Burton MJ (2011) Betahistine for Menière‘s disease syndrome. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD001873
Jiang M, Zhang Z, Zhao C (2020) What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere’s disease compared with steroids? A meta-analysis. J Neurol. https://doi.org/10.1007/s00415-020-10011-5
Kitahara M (Hrsg) (1990) Menière‘s disease. Springer, Berlin/Heidelberg/New York
Kocsis JH, Leon AC, Markowitz JC, Manber R, Arnow B, Klein DN, Thase ME (2009) Patient preference as a moderator of outcome for chronic forms of major depressive disorder treated with nefazodone, cognitive behavioral analysis system of psychotherapy, or their combination. J Clin Psychiat (3):354–361. https://doi.org/10.4088/JCP.08m04371
Krausbeck C (1984) Therapieergebnisse beim Morbus Menière. Dissertation, Universität Mainz
Lange G (1998) Die Gentamicin-Injektionstechnik: Eine Vereinfachung der transtympanalen Therapie des Morbus Menière. HNO 46:1000–1002
Link R, Berendes J, Zöller F (Hrsg) (1980) Handbuch der HNO-Heilkunde, Bd III, Teil II. Thieme, Stuttgart
Löhle E (1980) Der Einfluss einer sechswöchigen Vitaminmangelernährung auf die Sinneszellen des Innenohrs. Z Ernährungswiss 19:203–214
Martinez D (1972) The effect of Serc (betahistine hydrochloride) on the circulation of the inner ear in experimental animals. Acta Otolaryngol 305:29–47
Moller MN, Caye-Tomasen P, Thomsen JH (2009) Vestibular nerve section in the treatment of morbus Menière. Ugeskr Laeger 171(12):1000–1003
Montandon PB, Häusler RJ, Kimura RS (1985) Treatment of endolymphatic hydrops with cochleosacculotomy. Clinical results and experimental findings. Otolaryngol Head Neck Surg 93:615–621
Morgenstern C (1985) Pathophysiologie, Klinik und konservative Therapie der Menièreschen Erkrankung. Arch Otorhinolaryngol 1:1–66
Morgenstern C (1994) Morbus Menière. In: Naumann HH, Helms J, Herberhold C, Kastenabuer C (Hrsg) Oto-Rhino-Laryngologie in Klinik und Praxis, Bd 1: Ohr. Thieme, Stuttgart, S 768–775
Naganuma H, Kawahara K, Tokumasu K, Okamoto M (2006) Water may cure patients with Menière disease. Laryngoscope 116(8):1455–1460
Naples JG, Henry L, Brant JA, Eliades SJ, Ruckenstein MJ (2018) Intratympanic therapies in Ménière disease: evaluation of outcomes and early vertigo control. Laryngoscope. https://doi.org/10.1002/lary.27392
Nevoux J, Viengchareun S, Lema I, Lecoq AL, Ferrary E, Lombès M (2015) Glucocorticoids stimulate endolymphatic water reabsorption in inner ear through aquaporin 3 regulation. Pflugers Arch 467(9):1931–1943
Nevoux J, Barbara M, Dornhoffer J, Gibson W, Kitahara T, Darrouzet V (2018) International consensus (ICON) on treatment of Ménière’s disease. Eur Ann Otorhinolaryngol Head Neck Dis S1879-7296(18):30002–30004
Novoa E, Gärtner M, Henzen C (2014) Systemic effects of intratympanic dexamethasone therapy. Endocr Connect 3:127–131
Öztürk K, Ata N (2019) Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere’s disease. Am J Otolaryngol 40(5):711–714. https://doi.org/10.1016/j.amjoto.2019.06.008. Epub 2019 Jun 24
Paparella MM (2006) Endolymphatic sac revision for recurrent intractable Menière‘s disease. Otolaryngol Clin N Am 4:713–721
Park JJ, Luedeke I, Luecke K, Emmerling O, Westhofen M (2013) Eustachian tube function in patients with inner ear disorders. Eur Arch Otorhinolaryngol 270:1615–1621
Patel M, Agarwal K, Arshad Q, Hariri M, Rea P, Seemungal BM, Golding JF, Harcourt JP, Bronstein AM (2016) Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière’s disease: a randomised, double-blind, comparative eff ectiveness trial. Lancet 388:2753–2762
Plontke SK (2011) Evaluation of the round window niche before local drug delivery to the inner ear using a new mini-otoscope. Otol Neurotol 32:183–185
Plontke SK, Gürkov R (2015) Morbus Menière. Facharztwissen HNO. LRO 94:530–554
Plontke SK, Mynatt R, Gill RM (2007) Concentration gradient along the scala tympani after local application of gentamicin to the round window membrane. Laryngoscope 117:1191–1198
Postema RJ, Kingma CM, Wit HP (2008) Intratympanic gentamicin therapy for control of vertigo in unilateral Menire‘s disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol 128(8):876–880
Pullens B, van Benthem PP (2011) Intratympanic gentamicin for Menière‘s disease or syndrome Cochrane Database Syst Rev (3):CD008234
Pullens B, Giard JL, Verschuur HP, van Benthem PP (2021) Surgery for Ménière’s disease. Cochrane Database Syst Rev (1):Art. No.: CD005395. https://doi.org/10.1002/14651858.CD005395.pub2
Quaglieri S, Gatti O, Rebecchi E, Manfrin M, Tinelli C, Mira E, Benazzo M (2014) Intratympanic gentamicin treatment ‚as needed‘ for Meniere’s disease. Long-term analysis using the Kaplan-Meier method. Eur Arch Otorhinolaryngol 271:1443–1449
Radeloff A, Hamad M, Baier G, Helms J, Hagen R, Shehata-Dieler W (2009) Die Saccotomie in der Behandlung des M. Menière: Beurteilung der kurz-, mittel- und langfristigen Ergebnisse anhand eines Patientenfragebogens. Laryngorhino otologie 88:653–659
Rah YC, Han JJ, Park J, Choi BY, Koo JW (2014) Management of intractable Menière’s disease after intratympanic injection of Gentamicin. Laryngoscope 125(4):972–978. https://doi.org/10.1002/lary.v125.4/issuetoc
Rask-Andersen H, Danckwardt-Lilliestrom N, Friberg U (1991) Lymphocyte-macrophage activity in the human endolymphatic sac. Acta Otolaryngol Suppl 485:15–17
Reinecker H (2012) Verhaltenstherapie. In: Senf W, Broda M (Hrsg) Praxis der Psychotherapie. Thieme, Stuttgart, S 217–219
Ruckenstein MJ (2010) Ménière’s disease. Evidence and outcomes. Plural publishing, San Diego/Oxford/Brisbane, S S162
Saliba I, Gabra N, Alzahrani M et al (2015) Endolymphatic duct blockage: a randomized controlled trial of a novel surgical technique for Menière’s disease treatment. Otolaryngol Head Neck Surg 152(1):122–129
Salt AN, Gill RM, Plontke SK (2008) Dependence of hearing changes on the dose of intratympanically applied gentamicin: a meta-analysis using mathematical simulations of clinical drug delivery protocols. Laryngoscope 118:1793–1800
Schlegel M, Vibert D, Ott SR, Häusler R, Caversaccio MD (2012) Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Ménière’s disease. Otol Neurotol 33:1380–1385
Schmalzing G (2006) Wie gut ist die Arzneimitteltherapie des Hörsturzes wissenschaftlich belegt? In: Westhofen M (Hrsg) Vestibularfunktion. Brücke zwischen Forschung und Praxis. Springer, Heidelberg, S 43–62
Schmid G, Henningsen P, Dieterich M, Sattel H, Lahmann C (2011) Psychotherapy in dizziness: a systematic review. J Neurol Neurosurg Psychiatry 82:601e606. https://doi.org/10.1136/jnnp.2010.237388
Schuknecht HF (1957) Ablation therapy in the management of Menière‘s disease. Acta Otolaryngol Suppl 132:1–42
Sonsbeek van S, Pullens B, van Benthem P (2015) Positive pressure therapy for Menière’s disease or syndrome. Cochrane Database Syst Rev (3):Art. No.: CD008419. https://doi.org/10.1002/14651858.CD008419.pub2
Staab J (2012) Chronic Subjective Dizziness. Continuum 18(5):1118–1141
Stokroos R, Kingma H (2004) Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Menière‘s disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol 124(2):172–175
Strupp M, Kraus L, Schautzer F, Rujescu D (2018) Menière’s disease: combined pharmacotherapy with betahistine and the MAO-B inhibitor selegiline-an observational study. J Neurol. https://doi.org/10.1007/s00415-018-8809-8
Thomsen J, Bretlau P, Bretlau P, Tos M, Johnson NJ (1981) Placebo effect in the surgery of Menière‘s disease: a double blind, placebo-controlled study on endolymphatic sac surgery. Arch Otolaryngol 107:271–277
Trinidade A, Robinson T, Phillips JS (2014) The role of caffeine in otorhinolaryngology: guilty as charged? Eur Arch Otorhinolaryngol 271(8):2097–2102. https://doi.org/10.1007/s00405-013-2648-0
Tschan R, Eckhardt-Henn A, Scheurich V, Best C, Dieterich M, Beutel M (2012) Standfest? Erste Ergebnisse der Entwicklung eines kognitiv-verhaltenstherapeutischen Gruppenschulungsprogramms zur Behandlung des somatoformen Schwindels. Psychother Psychosom Med Psychol 62(3–4):111–119
Vosteen KH (Hrsg) (1981) Menière‘s disease. International symposium Düsseldorf. Thieme, Stuttgart
Walther LE (2005) Gestörtes Gleichgewicht: Wiederherstellende Verfahren bei gestörtem Gleichgewicht. Laryngo-Rhino-Otol 84:70–98. und http://www.thieme-connect.de/ejournals/abstract/lro/doi/10.1055/s-2005–861144)
Wang D, Wang Z (1997) Regeneration and functional restoration of vestibular hair cells in guinea pigs after gentamicin damage. Zhonghua Er Bi Yan Hou Ke Za Zhi 32:153–156
Weikert S, Rotter A, Scherer H, Hoelzl M (2008) Picrotoxin in der Therapie des Morbus Menière. Laryngorhinootologie 87(12):862–866
Westhofen M (2008) Die operative Therapie des vestibulären Schwindels. Verfahren und Indikationen. HNO 56:1003–1010
Westhofen M (2013) Indikation und Erfolge der operativen Therapie des vestibulären Schwindels. HNO 61:752–761
Wilson WR, Byl FM, Laird N (1980) The efficacy of steroids in the treatment of idiopathic sudden hearing loss. Arch Otolaryngol 106:772–776
Wirth W (2000) Psychologische Möglichkeiten bei Schwindel. Tinnitus-Forum 4/2000
Wolpe J (1958) Psychotherapy by reciprocal inhibition. Stanford University Press, Palo Alto
Yardley L, Kirby S (2006) Evaluation of booklet-based self-management of symptoms in Menière disease: a randomized controlled trial. Psychosom Med 68(5):762–769
Yardley L, Redfern MS (2001) Psychological factors influencing recovery from balance disorders. J Anxiety Disord 15(1–2):107–119
Yaz F, Ziylan F, Smeeing DPJ, Thomeer HGXM (2020) Intratympanic treatment in Menière’s disease, efficacy of aminoglycosides versus corticosteroids in comparison studies: a systematic review. Otol Neurotol 41(1):1–10. https://doi.org/10.1097/MAO.0000000000002451. PMID: 31789967
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature
About this chapter
Cite this chapter
Schaaf, H. (2021). Therapie des Morbus Menière. In: Morbus Menière. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64213-9_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-64213-9_7
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64212-2
Online ISBN: 978-3-662-64213-9
eBook Packages: Medicine (German Language)